Loading company…
National Resilience develops and manufactures complex medicines, including cell and gene therapies, biologics, and viral vectors.
Founded in 2020 by Drew Oetting and Rahul Singhvi, National Resilience is a contract development and manufacturing organization based in Blue Ash, US. It provides manufacturing services for complex medicines, including cell and gene therapies, biologics, and viral vectors. Its capabilities include manufacturing monoclonal antibodies, recombinant proteins, and viral vectors. The company is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in